Clinician Articles

26

Mar2019
This month Enzymotec, the makers of Vayarin, quietly announced on their website that they would no longer sell its product in the U.S. This leaves patients who have been taking it in ... Read More
March 26, 2019David W. Goodman, MD

07

Jun2018
Faraone SV, Silverstein MJ, Antshel K, Biederman J, Goodman DW, Mason O, Nierenberg AA, Rostain A, Stein MA, Adler LA.  J of Attention Disorder 2018:1-16 click to read abstract
June 7, 2018RoseMarie AddAdult

03

Mar2018
This is Part 2 to a previous blog: This brings us to the next objection insurance companies will raise – the issue of safety. In citing safety as a reason for ... Read More

03

Jun2017
National Public Radio recently posted my interview (click on "Heard on Morning Editon") from April 2017 about a research publication reviewing a revised adult ADHD screener developed in coordination with the ... Read More

29

Dec2015
American Professional Society for ADHD and Related Disorders has posted videos by many of the speakers at this year's conference. For those professionals and others who are interested in the ... Read More
December 29, 2015David W. Goodman, MD

22

Dec2015
On December 16, 2015, our article reviewing the world’s English scientific literature on ADHD in adults over age 50 years was published online in Drugs and Aging, an international journal. ... Read More
December 22, 2015David W. Goodman, MD

08

Dec2014
Over the years, it has been challenging for psychiatrists to manage the risks of psychiatric medications in patients who considered childbearing, become pregnant, and chose to breastfeed. And while there ... Read More
December 8, 2014David W. Goodman, MD

10

Sep2014
With an increasing number of adults being nearly diagnosed with ADHD, the expense of ADHD medications for insurance companies has escalated. While the annual prescription increase for childhood ADHD is ... Read More
September 10, 2014David W. Goodman, MD

16

Jul2014
Step therapy is the requirement that a patient first try less costly medication before being prescribed medication a doctor thinks is best for the individual patient and specific symptoms/history. In ... Read More

22

Apr2014
The following post from the FDA appeared today about complaints that generic long-acting methylphenidates (brand name-Concerta) may not work equally well. "In the case of the ADHD drug — certain generic ... Read More
April 22, 2014David W. Goodman, MD